Clinical Trials Rare diseases: how can decentralisation speed up trials and reduce patient burden? 26 Feb 2021
Bavarian doses first patient in CV301 and atezolizumab Phase ll trial Bavarian Nordic has dosed the first patient in a Phase ll trial to investigate CV301... 20th September 2018